EverSource Wealth Advisors »

Atea Pharmaceuticals shares owned by EverSource Wealth Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by EverSource Wealth Advisors from 13F filings

Historical chart of EverSource Wealth Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by EverSource Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by EverSource Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $230 69 3.35
2024-06-30 $450 118 3.82

More positions owned by EverSource Wealth Advisors

Vanguard Growth Etf Etf (VUG)
Vanguard Ftse Developed Markets Etf Etf (VEA)
Vanguard Value Etf Etf (VTV)
Apple Stock (AAPL)
iShares Gold Trust ETF Etf (IAU)
Spdr Bloomberg 1-3 Month T-bill Etf Etf (BIL)
Vanguard Dividend Appreciation Etf Etf (VIG)
Microsoft Corp Stock (MSFT)
Vanguard S&p 500 Etf Etf (VOO)
Vanguard Ftse Emerging Markets Etf Etf (VWO)
Sovereigns Capital Flourish Fund Etf (SOVF)
Vanguard Short-term Corporate Bond Etf Etf (VCSH)
Nvidia Corporation Stock (NVDA)
Tesla Stock (TSLA)
Vanguard Total Stock Market Etf Etf (VTI)

View all positions for EverSource Wealth Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BlackRock
BML Capital Management
EcoR1 Capital
Vanguard Group
Tang Capital Management
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Almitas Capital
Renaissance Technologies
Acadian Asset Management
Dimensional Fund Advisors
Northern Trust
Charles Schwab Investment Management

View all funds holding Atea Pharmaceuticals